Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization

PURPOSE: Skeletal muscle index (SMI) is a promising predictor of clinical outcomes in patients with malignant diseases. As a simpler surrogate of sarcopenia-psoas muscle index (PMI), its predict value for overall survival (OS) after transarterial chemoembolization (TACE) for hepatocellular carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jin-Xing, Yan, Hai-Tao, Ding, Ye, Liu, Jin, Liu, Sheng, Zu, Qing-Quan, Shi, Hai-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Gastroenterology & Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176702/
https://www.ncbi.nlm.nih.gov/pubmed/35639492
http://dx.doi.org/10.1080/07853890.2022.2081872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176702/
https://www.ncbi.nlm.nih.gov/pubmed/35639492
http://dx.doi.org/10.1080/07853890.2022.2081872

Ejemplares similares